The FDA does not have to speed up its approval process for medical devices and instead should focus on ensuring the efficiency of the device-development process so that safe products are produced and postmarket recalls are avoided, agency Commissioner Scott Gottlieb said in hearing held by a House Appropriations subpanel on Thursday. Gottlieb added that the FDA lifted its hiring freeze, allowing the agency to increase the number of experts for product reviews.
Gottlieb: FDA should focus on device-development process
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.